BACKGROUND
The scope of the present invention includes compounds and pharmaceutical compositions useful as anti-inflammatory agents.
Studies have shown that endogenous electrophilic unsaturated-nitrated fatty acids, including nitro-linoleic acid (LNO.sub.2) and nitro-oleic acid (OA-NO.sub.2), can